Kit ELISA sandwich Interleukin-10 (Eq IL-10) (horse): quantitative dosage of Eq IL-10 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Eq IL-10.
Accession number
Q28374
Dose range
0.102-25 ng/ml
Sensitivity of the dosage
90 pg/ml
Calibration range
90 pg/ml at 25 ng/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA sandwich Interleukin-10 (Eq IL-10) (horse): quantitative dosage of Eq IL-10 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Eq IL-10.
Kit ELISA sandwich Interleukin-10 (Eq IL-10) (horse): quantitative dosage of Eq IL-10 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Eq IL-10.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The interleukin-10 is a pleiotropic cytokine that plays an important role in regulating the function of lymphoid and myeloid cells. In humans, CD8(+) activated peripheral blood T cells produce the IL-10 using auxiliary CD4(+) T cells. Due to the ability of the IL-10 to block cytokine synthesis and several cell functions associated with macrophages, this cytokine is a potent suppressor of the effector functions of macrophages, T cells, and NK cells. In addition, the IL-10 helps regulate the proliferation and differentiation of B cells, mast cells and thymocytes. The primary structure of human IL-10 was determined by cloning of cytokine-encoded cDNA. The corresponding protein produces 160 amino acids of predicted molecular mass of 18.5 kDa. Depending on its primary structure, the IL-10 belongs to the family of 4-proplin cytokines a. In solution, the human IL-10 is a homodimer with an apparent molecular mass of 39 kDa. Although it contains a N-binding glycosylation site, this protein lacks detectable carbohydrates. Therefore, the recombinant protein expressed in E. coli retains all known biological activities. The human IL-10 gene is found on chromosome 1 and appears in only one copy in the genome. The human IL-10 has a strong homology of sequence d-DNA and amino acids with murine IL-10 and an open reading frame in the genome of the virus d-Epstein-Barr, BCRF1, which shares many biological activities of cell cytokine and can thus play a role in host-virus interaction. Immunosuppressive properties of the IL-10 suggest a possible clinical use of the IL-10 in the suppression of transplant discharges following organ transplantation. In addition, the IL-10 can have strong anti-inflammatory activities.